ŠTĚPÁNKOVÁ, Kateřina, Kadir OZALTIN, Radka GOREJOVÁ, Hana DOUDOVÁ, Eva BERGEROVÁ, Iveta MASKALOVÁ, Monika STUPAVSKÁ, Pavel SŤAHEL, David TRUNEC, Jana PELKOVÁ, Miran MOZETIČ and Marián LEHOCKÝ. Sulfation of furcellaran and its effect on hemocompatibility in vitro. International Journal of Biological Macromolecules. Amsterdam: Elsevier Science BV, 2024, vol. 258, No 1, p. 128840-128851. ISSN 0141-8130. Available from: https://dx.doi.org/10.1016/j.ijbiomac.2023.128840.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Sulfation of furcellaran and its effect on hemocompatibility in vitro
Authors ŠTĚPÁNKOVÁ, Kateřina (203 Czech Republic), Kadir OZALTIN (203 Czech Republic), Radka GOREJOVÁ (703 Slovakia), Hana DOUDOVÁ (203 Czech Republic), Eva BERGEROVÁ (203 Czech Republic), Iveta MASKALOVÁ (703 Slovakia), Monika STUPAVSKÁ (203 Czech Republic, belonging to the institution), Pavel SŤAHEL (203 Czech Republic, belonging to the institution), David TRUNEC (203 Czech Republic, guarantor, belonging to the institution), Jana PELKOVÁ (203 Czech Republic), Miran MOZETIČ (705 Slovenia) and Marián LEHOCKÝ (203 Czech Republic).
Edition International Journal of Biological Macromolecules, Amsterdam, Elsevier Science BV, 2024, 0141-8130.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10608 Biochemistry and molecular biology
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 8.200 in 2022
Organization unit Faculty of Science
Doi http://dx.doi.org/10.1016/j.ijbiomac.2023.128840
UT WoS 001137688700001
Keywords in English Anticoagulant; Furcellaran; Hemocompatibility; Platelet adhesion; Seaweed polysaccharide; Sulfation
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Marie Šípková, DiS., učo 437722. Changed: 29/1/2024 10:11.
Abstract
In this study, furcellaran (FUR) obtained from Furcellaria lumbricalis was firstly employed for sulfation via various methods, including SO3-pyridine (SO3∙Py) complex in different aprotic solvents, chlorosulfonic acid and sulfuric acid with a "coupling" reagent N,N'-Dicyclohexylcarbodiimide. Structural characterization through FT-IR, GPC, XPS and elemental analyses confirmed the successful synthesis of 6-O-sulfated FUR derivates characterized by varying degrees of sulfation (DS) ranging from 0.15 to 0.91 and molecular weight (Mw) spanning from12.5kDa to 2.7kDa. In vitro clotting assays, partial thromboplastin time (aPTT), thrombin time (TT), and prothrombin time (PT) underscored the essential role of sulfate esters in conferring anticoagulant activity whereas FUR prepared via chlorosulfonic acid with DS of 0.91 reached 311.4s in aPPT showing almost 4-fold higher anticoagulant activity than native FUR at the concentration 2mg/mL. MTT test showed all tested samples decreased cell viability in a dose dependent manner while all of them are non-cytotoxic up to the concentration of 0.1mg/mL. Furthermore, sulfated derivates deposited onto polyethylene terephthalate surface presented substantial decrease in platelet adhesion, as well as absence of the most activated platelet stages. These findings support the pivotal role of O-6 FUR sulfates in enhancing hemocompatibility and provide valuable insights for a comparative assessment of effective sulfating approaches.
PrintDisplayed: 30/5/2024 21:27